These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34019757)

  • 1. Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended
    Pasieka A; Panek D; Szałaj N; Espargaró A; Więckowska A; Malawska B; Sabaté R; Bajda M
    ACS Chem Neurosci; 2021 Jun; 12(11):2057-2068. PubMed ID: 34019757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.
    Panek D; Więckowska A; Jończyk J; Godyń J; Bajda M; Wichur T; Pasieka A; Knez D; Pišlar A; Korabecny J; Soukup O; Sepsova V; Sabaté R; Kos J; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1074-1094. PubMed ID: 29345897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
    Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
    Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
    Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies.
    Mohamed T; Rao PPN
    Eur J Med Chem; 2017 Jan; 126():823-843. PubMed ID: 27951490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters.
    Pasieka A; Panek D; Jończyk J; Godyń J; Szałaj N; Latacz G; Tabor J; Mezeiova E; Chantegreil F; Dias J; Knez D; Lu J; Pi R; Korabecny J; Brazzolotto X; Gobec S; Höfner G; Wanner K; Więckowska A; Malawska B
    Eur J Med Chem; 2021 Jun; 218():113397. PubMed ID: 33838585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.
    Panek D; Więckowska A; Wichur T; Bajda M; Godyń J; Jończyk J; Mika K; Janockova J; Soukup O; Knez D; Korabecny J; Gobec S; Malawska B
    Eur J Med Chem; 2017 Jan; 125():676-695. PubMed ID: 27721153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents.
    Panek D; Więckowska A; Pasieka A; Godyń J; Jończyk J; Bajda M; Knez D; Gobec S; Malawska B
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29414887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
    Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
    Jiang N; Ding J; Liu J; Sun X; Zhang Z; Mo Z; Li X; Yin H; Tang W; Xie SS
    Bioorg Chem; 2019 Aug; 89():103027. PubMed ID: 31176237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
    García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
    Lan JS; Hou JW; Liu Y; Ding Y; Zhang Y; Li L; Zhang T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):776-788. PubMed ID: 28585866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
    Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
    Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease.
    Campora M; Canale C; Gatta E; Tasso B; Laurini E; Relini A; Pricl S; Catto M; Tonelli M
    ACS Chem Neurosci; 2021 Feb; 12(3):447-461. PubMed ID: 33428389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Quinolinone Hybrids as Dual Inhibitors of Acetylcholinesterase and Aβ Aggregation for Alzheimer's Disease Therapy.
    Manzoor S; Gabr MT; Nafie MS; Raza MK; Khan A; Nayeem SM; Arafa RK; Hoda N
    ACS Chem Neurosci; 2024 Feb; 15(3):539-559. PubMed ID: 38149821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
    Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
    Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.